| Trial ID: | L7092 |
| Source ID: | NCT00642798
|
| Associated Drug: |
Sitagliptin Phosphate
|
| Title: |
An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Non-insulin-dependent
|
| Interventions: |
DRUG: sitagliptin phosphate
|
| Outcome Measures: |
Primary: Pharmacokinetics of sitagliptin after administration of single and multiple 100-mg doses of sitagliptin to healthy chinese adult subjects., Duration of Trial |
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-03
|
| Completion Date: |
2008-03
|
| Results First Posted: |
|
| Last Update Posted: |
2015-02-03
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00642798
|
